Efficiency of Helicobacter pylori Infection Treatment Protocol: Clarithromycin, Amoxicillin and Omeprazole

Message:
Abstract:
Background
Helicobacter pylori (H. pylori) is one of the most common pathogen affecting humans, which is approximately infecting 50% of the world population and remains as a significant cause of morbidity and mortality. Since the discovery of Helicobacter pylori in early 1980, many treatment regimens have been developed to effectively treat this infection. Despite the extensive research over the last 25 years the treatment of Helicobacter pylori remains a challenging clinical problem due to its antimicrobial resistance..
Objectives
This study aimed to evaluate Clarithromycin, Amoxicillin and Omeprazole efficiency as a treatment for H. pylori..Patients and
Methods
The patients with clinical features of H. pylori infection and positive serological and clinical test results were entered to the study. Whole of the patients enrolled in the study were given a full two weeks of effective treatment protocol of H. pylori consisted of Clarithromycin (20 mg PO bid), Amoxicillin (1 g PO bid) and Omeprazole (20 mg PO bid) together. Our variables in this study were blood IgG and CagA factor levels, which were collected using serological tests and the H. pylori stool antigen was another variable in the study which was taken from stool tests..
Results
Results showed that the mean level of IgG and CagA of blood samples was lower in the study group than the control one. Moreover, the average level of H. pylori antigen in stool was lower after the treatment..
Conclusions
The result of our study showed that using Clarithromycin, Amoxicillin and Omeprazole for treatment of H. pylori infection can be useful. It is concluded from lower levels of IgG and CagA in blood and H. pylori antigen in stool after treatment compared to the amount of these factors before therapy. Considering all these data, it is obvious that there is an urgent need to found a better therapy and treatment for H. pylori infections in which it cause low bacterial resistance..
Language:
English
Published:
Archives of Clinical Infectious Diseases, Volume:8 Issue: 1, Jan 2013
Pages:
14 to 17
https://www.magiran.com/p1223217  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با ثبت ایمیلتان و پرداخت حق اشتراک سالانه به مبلغ 1,490,000ريال، بلافاصله متن این مقاله را دریافت کنید.اعتبار دانلود 70 مقاله نیز در حساب کاربری شما لحاظ خواهد شد.

پرداخت حق اشتراک به معنای پذیرش "شرایط خدمات" پایگاه مگیران از سوی شماست.

اگر مقاله ای از شما در مگیران نمایه شده، برای استفاده از اعتبار اهدایی سامانه نویسندگان با ایمیل منتشرشده ثبت نام کنید. ثبت نام

اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!